A recent study published in the journal Cell Host & Microbe by researchers at McMaster University has unveiled promising insights into peanut allergies. The research indicates that specific bacteria present in the human mouth and gut can decompose proteins responsible for triggering allergic reactions to peanuts. Notably, these beneficial microbes are already part of the body’s microbiome, residing in the oral cavity and digestive tract.
The study highlights the role of several microbes in degrading two peanut proteins most commonly associated with allergic responses, identified as Ara h 1 and Ara h 2. Among the bacteria examined, Rothia aeria emerged as particularly effective. In laboratory experiments, this microbe was shown to nearly eliminate both allergen proteins, suggesting its potential to mitigate the immune reaction that can lead to severe allergic responses, including life-threatening breathing difficulties.
Peanut allergies affect approximately two percent of the population in Western countries and are known for their persistence, often continuing into adulthood. Even minimal exposure to peanuts can trigger symptoms ranging from hives to severe anaphylaxis, a condition that can be fatal.
To delve deeper into the mechanisms behind peanut allergies, the research team collected saliva samples from volunteers without food allergies. They assessed how effectively these oral microbes could break down peanut proteins in controlled lab settings. Additionally, mouse models with peanut allergies were utilized to observe the impact of these bacteria on immune responses.
The findings revealed a notable correlation: individuals with a higher tolerance to peanut exposure generally possessed more Rothia aeria in their saliva. This discovery opens the door to the development of probiotic treatments aimed at enhancing microbial populations like Rothia aeria in the body. Such treatments could complement existing methods, such as oral immunotherapy, which involves gradually exposing patients to small amounts of allergens to help them build immunity over time.
This innovative research not only sheds light on the complexities of peanut allergies but also brings hope for new therapeutic strategies that could alleviate the burden on those affected. As the study progresses, the potential for harnessing the body’s own microbiome to combat allergic reactions represents a significant advancement in allergy management.
